Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis
Background & Aims : To clarify whether aspirin-dialminate administration suppresses the serum phosphorus (P) level in hemodialysis patients. Methods : The subjects were 13 hemodialysis patients who required antiplatelet therapy with aspirin-dialminate. Serum P and calcium (Ca) levels and the Ca-...
Gespeichert in:
| Veröffentlicht in: | Kita Kantō igaku (The Kitakanto Medical Journal) 2004/01/01, Vol.54(1), pp.5-8 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | 1 |
| container_start_page | 5 |
| container_title | Kita Kantō igaku (The Kitakanto Medical Journal) |
| container_volume | 54 |
| creator | Ito, Kazuto Ono, Yoshihiro Hatori, Motoaki Suzuki, Kazuhiro Fukabori, Yoshitatsu Yamanaka, Hidetoshi Hamano, Tatsuya Matsumoto, Kazuhisa Hayashi, Masamichi Kosaku, Nozomu |
| description | Background & Aims : To clarify whether aspirin-dialminate administration suppresses the serum phosphorus (P) level in hemodialysis patients. Methods : The subjects were 13 hemodialysis patients who required antiplatelet therapy with aspirin-dialminate. Serum P and calcium (Ca) levels and the Ca-P product were measured after aspirin-dialminate administration, and they were compared with the levels before treatment. Results : Serum P level decreased from 5.66±1.45 to 4.72 ± 0.92 mg/dL, and the Ca-P product decreased from 53.4± 16.0 to 44.3 ± 10.3 after one month of aspirin-dialminate intake (p < 0.05), however, these effects were not maintained after 2 and 3 months. Serum Ca levels showed no change through the period of the present study. Conclusions : Aspirin-dialminate has an intermittent and limited effect on suppressing the serum P level and the Ca-P product in hemodialysis patients. |
| doi_str_mv | 10.2974/kmj.54.5 |
| format | Article |
| fullrecord | <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2974_kmj_54_5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_kmj1997_54_1_54_1_5_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2855-3c2067bef1792a9f6e82fa04d9101ec9c6cf5fe657b0fb3d91ae47721213e4b23</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMoWKvgT8jRy9Z87m6OpVQrFCy0npdsOnFT98tkq_Tfm8XSy8ww78NzeBF6pGTGVCaev5rDTIqZvEITmuc0oVTR63hzwROWs_QW3YVwIESmiosJ-l5aC2YIuLN4HnrnXZvsna4b1-oBcNfi7bHvPYTg4u1aPFSAt-CPDd5UXeirzh8DXsMP1GGMN3pw0EbfzkMU7PGvGyq8gqYbrafgwj26sboO8HDeU_TxstwtVsn6_fVtMV8nhuVSJtwwkmYlWJopppVNIWdWE7FXlFAwyqTGSgupzEpiSx7fGkSWMcooB1EyPkVP_17juxA82KL3rtH-VFBSjFUVsapCikJGdP6PHsKgP-ECaj84U8MIUqWyEabncclMpX0BLf8Da5B16w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ito, Kazuto ; Ono, Yoshihiro ; Hatori, Motoaki ; Suzuki, Kazuhiro ; Fukabori, Yoshitatsu ; Yamanaka, Hidetoshi ; Hamano, Tatsuya ; Matsumoto, Kazuhisa ; Hayashi, Masamichi ; Kosaku, Nozomu</creator><creatorcontrib>Ito, Kazuto ; Ono, Yoshihiro ; Hatori, Motoaki ; Suzuki, Kazuhiro ; Fukabori, Yoshitatsu ; Yamanaka, Hidetoshi ; Hamano, Tatsuya ; Matsumoto, Kazuhisa ; Hayashi, Masamichi ; Kosaku, Nozomu</creatorcontrib><description>Background & Aims : To clarify whether aspirin-dialminate administration suppresses the serum phosphorus (P) level in hemodialysis patients. Methods : The subjects were 13 hemodialysis patients who required antiplatelet therapy with aspirin-dialminate. Serum P and calcium (Ca) levels and the Ca-P product were measured after aspirin-dialminate administration, and they were compared with the levels before treatment. Results : Serum P level decreased from 5.66±1.45 to 4.72 ± 0.92 mg/dL, and the Ca-P product decreased from 53.4± 16.0 to 44.3 ± 10.3 after one month of aspirin-dialminate intake (p < 0.05), however, these effects were not maintained after 2 and 3 months. Serum Ca levels showed no change through the period of the present study. Conclusions : Aspirin-dialminate has an intermittent and limited effect on suppressing the serum P level and the Ca-P product in hemodialysis patients.</description><identifier>ISSN: 1343-2826</identifier><identifier>EISSN: 1881-1191</identifier><identifier>DOI: 10.2974/kmj.54.5</identifier><language>eng</language><publisher>The Kitakanto Medical Society</publisher><subject>aspirin-dialminate ; calcium ; chronic renal failure ; hemodialysis ; phosphorus</subject><ispartof>The Kitakanto Medical Journal, 2004/01/01, Vol.54(1), pp.5-8</ispartof><rights>The Kitakanto Medical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025,27927,27928,27929</link.rule.ids></links><search><creatorcontrib>Ito, Kazuto</creatorcontrib><creatorcontrib>Ono, Yoshihiro</creatorcontrib><creatorcontrib>Hatori, Motoaki</creatorcontrib><creatorcontrib>Suzuki, Kazuhiro</creatorcontrib><creatorcontrib>Fukabori, Yoshitatsu</creatorcontrib><creatorcontrib>Yamanaka, Hidetoshi</creatorcontrib><creatorcontrib>Hamano, Tatsuya</creatorcontrib><creatorcontrib>Matsumoto, Kazuhisa</creatorcontrib><creatorcontrib>Hayashi, Masamichi</creatorcontrib><creatorcontrib>Kosaku, Nozomu</creatorcontrib><title>Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis</title><title>Kita Kantō igaku (The Kitakanto Medical Journal)</title><addtitle>Kitakanto Med J</addtitle><description>Background & Aims : To clarify whether aspirin-dialminate administration suppresses the serum phosphorus (P) level in hemodialysis patients. Methods : The subjects were 13 hemodialysis patients who required antiplatelet therapy with aspirin-dialminate. Serum P and calcium (Ca) levels and the Ca-P product were measured after aspirin-dialminate administration, and they were compared with the levels before treatment. Results : Serum P level decreased from 5.66±1.45 to 4.72 ± 0.92 mg/dL, and the Ca-P product decreased from 53.4± 16.0 to 44.3 ± 10.3 after one month of aspirin-dialminate intake (p < 0.05), however, these effects were not maintained after 2 and 3 months. Serum Ca levels showed no change through the period of the present study. Conclusions : Aspirin-dialminate has an intermittent and limited effect on suppressing the serum P level and the Ca-P product in hemodialysis patients.</description><subject>aspirin-dialminate</subject><subject>calcium</subject><subject>chronic renal failure</subject><subject>hemodialysis</subject><subject>phosphorus</subject><issn>1343-2826</issn><issn>1881-1191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNo9kE1LAzEQhoMoWKvgT8jRy9Z87m6OpVQrFCy0npdsOnFT98tkq_Tfm8XSy8ww78NzeBF6pGTGVCaev5rDTIqZvEITmuc0oVTR63hzwROWs_QW3YVwIESmiosJ-l5aC2YIuLN4HnrnXZvsna4b1-oBcNfi7bHvPYTg4u1aPFSAt-CPDd5UXeirzh8DXsMP1GGMN3pw0EbfzkMU7PGvGyq8gqYbrafgwj26sboO8HDeU_TxstwtVsn6_fVtMV8nhuVSJtwwkmYlWJopppVNIWdWE7FXlFAwyqTGSgupzEpiSx7fGkSWMcooB1EyPkVP_17juxA82KL3rtH-VFBSjFUVsapCikJGdP6PHsKgP-ECaj84U8MIUqWyEabncclMpX0BLf8Da5B16w</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Ito, Kazuto</creator><creator>Ono, Yoshihiro</creator><creator>Hatori, Motoaki</creator><creator>Suzuki, Kazuhiro</creator><creator>Fukabori, Yoshitatsu</creator><creator>Yamanaka, Hidetoshi</creator><creator>Hamano, Tatsuya</creator><creator>Matsumoto, Kazuhisa</creator><creator>Hayashi, Masamichi</creator><creator>Kosaku, Nozomu</creator><general>The Kitakanto Medical Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2004</creationdate><title>Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis</title><author>Ito, Kazuto ; Ono, Yoshihiro ; Hatori, Motoaki ; Suzuki, Kazuhiro ; Fukabori, Yoshitatsu ; Yamanaka, Hidetoshi ; Hamano, Tatsuya ; Matsumoto, Kazuhisa ; Hayashi, Masamichi ; Kosaku, Nozomu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2855-3c2067bef1792a9f6e82fa04d9101ec9c6cf5fe657b0fb3d91ae47721213e4b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>aspirin-dialminate</topic><topic>calcium</topic><topic>chronic renal failure</topic><topic>hemodialysis</topic><topic>phosphorus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Kazuto</creatorcontrib><creatorcontrib>Ono, Yoshihiro</creatorcontrib><creatorcontrib>Hatori, Motoaki</creatorcontrib><creatorcontrib>Suzuki, Kazuhiro</creatorcontrib><creatorcontrib>Fukabori, Yoshitatsu</creatorcontrib><creatorcontrib>Yamanaka, Hidetoshi</creatorcontrib><creatorcontrib>Hamano, Tatsuya</creatorcontrib><creatorcontrib>Matsumoto, Kazuhisa</creatorcontrib><creatorcontrib>Hayashi, Masamichi</creatorcontrib><creatorcontrib>Kosaku, Nozomu</creatorcontrib><collection>CrossRef</collection><jtitle>Kita Kantō igaku (The Kitakanto Medical Journal)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Kazuto</au><au>Ono, Yoshihiro</au><au>Hatori, Motoaki</au><au>Suzuki, Kazuhiro</au><au>Fukabori, Yoshitatsu</au><au>Yamanaka, Hidetoshi</au><au>Hamano, Tatsuya</au><au>Matsumoto, Kazuhisa</au><au>Hayashi, Masamichi</au><au>Kosaku, Nozomu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis</atitle><jtitle>Kita Kantō igaku (The Kitakanto Medical Journal)</jtitle><addtitle>Kitakanto Med J</addtitle><date>2004</date><risdate>2004</risdate><volume>54</volume><issue>1</issue><spage>5</spage><epage>8</epage><pages>5-8</pages><issn>1343-2826</issn><eissn>1881-1191</eissn><abstract>Background & Aims : To clarify whether aspirin-dialminate administration suppresses the serum phosphorus (P) level in hemodialysis patients. Methods : The subjects were 13 hemodialysis patients who required antiplatelet therapy with aspirin-dialminate. Serum P and calcium (Ca) levels and the Ca-P product were measured after aspirin-dialminate administration, and they were compared with the levels before treatment. Results : Serum P level decreased from 5.66±1.45 to 4.72 ± 0.92 mg/dL, and the Ca-P product decreased from 53.4± 16.0 to 44.3 ± 10.3 after one month of aspirin-dialminate intake (p < 0.05), however, these effects were not maintained after 2 and 3 months. Serum Ca levels showed no change through the period of the present study. Conclusions : Aspirin-dialminate has an intermittent and limited effect on suppressing the serum P level and the Ca-P product in hemodialysis patients.</abstract><pub>The Kitakanto Medical Society</pub><doi>10.2974/kmj.54.5</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1343-2826 |
| ispartof | The Kitakanto Medical Journal, 2004/01/01, Vol.54(1), pp.5-8 |
| issn | 1343-2826 1881-1191 |
| language | eng |
| recordid | cdi_crossref_primary_10_2974_kmj_54_5 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | aspirin-dialminate calcium chronic renal failure hemodialysis phosphorus |
| title | Effects of Aspirin-dialminate on Suppression in the Serum Phosphorus Levels in Patients Treated with Hemodialysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A56%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Aspirin-dialminate%20on%20Suppression%20in%20the%20Serum%20Phosphorus%20Levels%20in%20Patients%20Treated%20with%20Hemodialysis&rft.jtitle=Kita%20Kant%C5%8D%20igaku%20(The%20Kitakanto%20Medical%20Journal)&rft.au=Ito,%20Kazuto&rft.date=2004&rft.volume=54&rft.issue=1&rft.spage=5&rft.epage=8&rft.pages=5-8&rft.issn=1343-2826&rft.eissn=1881-1191&rft_id=info:doi/10.2974/kmj.54.5&rft_dat=%3Cjstage_cross%3Earticle_kmj1997_54_1_54_1_5_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |